Skye Bioscience, Inc. (SKYE)
1.86
+0.08
(+4.49%)
USD |
NASDAQ |
Sep 04, 16:00
1.86
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Net Income (Annual) : -55.92M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -55.92M |
| December 31, 2024 | -26.57M |
| December 31, 2023 | -37.64M |
| December 31, 2022 | -19.48M |
| December 31, 2021 | -8.522M |
| December 31, 2020 | -6.561M |
| December 31, 2019 | 1.052M |
| December 31, 2018 | -19.19M |
| Date | Value |
|---|---|
| December 31, 2017 | -3.094M |
| December 31, 2016 | -3.178M |
| December 31, 2015 | -4.841M |
| December 31, 2014 | -2.734M |
| October 31, 2013 | -0.0038M |
| October 31, 2012 | 0.0045M |
| October 31, 2011 | -0.004M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 4.505B |
| Viking Therapeutics, Inc. | -359.64M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |